Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP46A1 | Q9Y6A2 | 7/20 | 0.43 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.42 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.42 |
| ▸ | PRMT5 | O14744 | 4/20 | 0.42 |
| ▸ | GPR119 | Q8TDV5 | 4/20 | 0.42 |
| ▸ | YAP1 | P46937 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.40 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.40 |
| ▸ | AVPR1B | P47901 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26641553 | 0.91 | OPRD1 (0.42) | OPRD1OPRK1PRMT5GPR119YAP1 | |
| SCHEMBL27039398 | 0.89 | OPRD1 (0.45) | OPRD1OPRK1PRMT5GPR119ACHE | |
| SCHEMBL30643684 | 0.86 | OPRD1 (0.42) | OPRD1OPRK1PRMT5GPR119YAP1 | |
| SCHEMBL30830495 | 0.85 | GPR119 (0.47) | OPRD1OPRK1PRMT5GPR119ACHE | |
| SCHEMBL30830629 | 0.85 | CYP3A4 (0.48) | OPRD1OPRK1PRMT5GPR119 | |
| SCHEMBL31727842 | 0.84 | CYP3A4 (0.47) | OPRD1OPRK1PRMT5GPR119 | |
| SCHEMBL23301621 | 0.84 | GPR119 (0.54) | GPR119ACHE | |
| SCHEMBL24206930 | 0.82 | PRMT5 (0.52) | PRMT5GPR119YAP1 | |
| SCHEMBL30769460 | 0.82 | CYP11B2 (0.48) | OPRD1OPRK1PRMT5GPR119 | |
| Hydrochloric Acid SCHEMBL31727600 | 0.82 | CYP11B2 (0.47) | OPRD1OPRK1PRMT5GPR119 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120092003-A | CDK protein degrading agents, pharmaceutical compositions and therapeutic uses | 拜欧斯瑞克斯公司 | 2025-06-03 | — | — | CN | disclosed |
| WO-2023220640-A1 | CDK PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS | BIOTHERYX, INC. (US) | 2023-11-16 | — | — | WO | disclosed |